Indication
Cervical Squamous Intraepithelial Neoplasia 2
2 clinical trials
3 products
Clinical trial
A Phase II Open-Label, Single Arm Pilot Study to Evaluate the Safety and Efficacy of Pembrolizumab for High-Grade Cervical Intraepithelial NeoplasiaStatus: Recruiting, Estimated PCD: 2025-01-31
Product
PembrolizumabClinical trial
A Feasibility Trial of Alternating Intravaginal Application of 5-Fluorouracil and Imiquimod for Treatment of High-Grade Cervical Squamous Intraepithelial LesionsStatus: Active (not recruiting), Estimated PCD: 2020-11-04
Product
ImiquimodProduct
Topical Fluorouracil